Tvardi Therapeutics (TVRD) Revenue: 2013-2017
Historic Revenue for Tvardi Therapeutics (TVRD) over the last 2 years, with Mar 2017 value amounting to $911,000.
- Tvardi Therapeutics' Revenue rose 12914.29% to $911,000 in Q1 2017 from the same period last year, while for Mar 2017 it was $3.4 million, marking a year-over-year decrease of 9.79%. This contributed to the annual value of $86,000 for FY2016, which is 97.74% down from last year.
- According to the latest figures from Q1 2017, Tvardi Therapeutics' Revenue is $911,000, which was up 1,053.16% from $79,000 recorded in Q2 2016.
- Tvardi Therapeutics' 5-year Revenue high stood at $2.4 million for Q3 2015, and its period low was $7,000 during Q1 2016.
- Its 3-year average for Revenue is $800,000, with a median of $681,500 in 2015.
- Its Revenue has fluctuated over the past 5 years, first crashed by 98.57% in 2016, then skyrocketed by 12,914.29% in 2017.
- Quarterly analysis of 5 years shows Tvardi Therapeutics' Revenue stood at $973,000 in 2013, then fell by 6.06% to $914,000 in 2014, then spiked by 116.89% to $2.4 million in 2015, then plummeted by 90.96% to $79,000 in 2016, then spiked by 12,914.29% to $911,000 in 2017.
- Its last three reported values are $911,000 in Q1 2017, $79,000 for Q2 2016, and $7,000 during Q1 2016.